Using the CRISPR genome-editing technology that won UC Berkeley's Jennifer Doudna a share of the 2020 Nobel Prize in chemistry, the company has a potential cure for HIV in an early-stage clinical trial.
Using the CRISPR genome-editing technology that won UC Berkeley's Jennifer Doudna a share of the 2020 Nobel Prize in chemistry, the company has a potential cure for HIV in an early-stage clinical trial.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.